Vanda Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vanda Pharmaceuticals Inc
TickerVNDA
CIK #0001347178
CUSIP921659108
SectorLife Sciences - Pharmaceutical Preparations
Address9605 Medical Center Drive Suite 300, Rockville, MD 20850
Source [EDGAR]
CIK Filing 2011 - 2025
[0001347178] 10-K
[0001347178] 10-Q
[0001347178] 3
[0001347178] 4
[0001347178] 5
[0001347178] 8-K
[0001347178] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Millennium Management LLC Vanda Pharmaceuticals Inc [2025-07-01] 0.0
BlackRock Portfolio Management LLC Vanda Pharmaceuticals Inc [2025-04-15] 0.0
Dimensional Fund Advisors LP Vanda Pharmaceuticals Inc [2023-02-10] 5.0
State Street Corp Vanda Pharmaceuticals Inc [2021-02-11] 5.86
BlackRock Inc Vanda Pharmaceuticals Inc [2021-01-25] 17.9
Renaissance Technologies LLC Vanda Pharmaceuticals Inc [2020-02-12] 6.47
Armistice Capital LLC Vanda Pharmaceuticals Inc [2019-06-24] 6.2
Consonance Capital Management LP Vanda Pharmaceuticals Inc [2019-02-14] 8.53
Macquarie Group Ltd Vanda Pharmaceuticals Inc [2018-02-14] 5.02
Vanguard Group Inc Vanda Pharmaceuticals Inc [2018-02-09] 6.3
Armistice Capital LLC Vanda Pharmaceuticals Inc [2017-06-19] 5.1
Great Point Partners LLC Vanda Pharmaceuticals Inc [2017-02-17] 5.04
Point72 Asset Management LP Vanda Pharmaceuticals Inc [2017-02-16] 5.0
Integrated Core Strategies US LLC Vanda Pharmaceuticals Inc [2016-01-27] 4.3
Great Point Partners LLC Vanda Pharmaceuticals Inc [2016-01-15] 5.45
Stonepine Capital Management LLC Vanda Pharmaceuticals Inc [2015-07-02] 5.5
Armistice Capital LLC Vanda Pharmaceuticals Inc [2015-03-27] 5.5
Paulson & Co Inc Vanda Pharmaceuticals Inc [2015-02-17] 0.14
Flynn James E Vanda Pharmaceuticals Inc [2014-08-01] 6.09
Price T Rowe Associates Inc /MD/ Vanda Pharmaceuticals Inc [2014-07-10] 10.1
Palo Alto Investors LLC Vanda Pharmaceuticals Inc [2014-02-14] 0.8
Kingdon Capital Management LLC Vanda Pharmaceuticals Inc [2014-02-14] 6.75
FMR LLC Vanda Pharmaceuticals Inc [2013-12-10] 0.0
Integrated Core Strategies US LLC Vanda Pharmaceuticals Inc [2013-10-11] 2.7
Baker Bros Advisors LLC Vanda Pharmaceuticals Inc [2013-06-10] 14.0
Palo Alto Investors LLC Vanda Pharmaceuticals Inc [2013-02-14] 5.1
First Eagle Investment Management LLC Vanda Pharmaceuticals Inc [2013-02-11] 6.77
[2012-12-10] None
Tang Capital Partners LP Vanda Pharmaceuticals Inc [2012-04-20] 6.9
Form 3/4/5 Filer 2011 - 2025
Vanda Pharmaceuticals Inc.
Polymeropoulos Mihael Hristos
Mitchell Stephen Ray
Dugan Richard W
Honore Tage
Ward Anne Sempowski
Chrousos Phaedra
Wijkstrom Joakim
Williams Timothy
Moran Kevin Patrick
Birznieks Gunther
Watkins Thomas
Jones Aranthan II
Reverberi Gian Piero
Kelly James Patrick
Cola Michael F
Milano Vincent
Gulino Richard L.
Bate Kenneth
Baroldi Paolo
Deerfield Mgmt L.P.
Flynn James E
Deerfield International Master Fund, L.P.
Deerfield Special Situations Fund, L.P.
Deerfield Management Company LP
Deerfield Partners LP
Pien Howard H
Gibbs Thomas Edward
Deerfield Special Situations International Master Fund, L.P.
Galson Steven K
Repella Robert
Feeney John Joseph
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 8,511,442 9,435,626
Vanguard Group Inc [2025-06-30] SOLE 0 3,472,044
Renaissance Technologies LLC [2025-06-30] SOLE 3,447,460 3,447,460
Millennium Management LLC [2025-06-30] SOLE 3,120,339 3,120,339
Dimensional Fund Advisors LP [2025-06-30] SOLE 2,382,498 2,452,543
Tang Capital Management LLC [2025-06-30] OTR 0 2,353,307
Geode Capital Management LLC [2025-06-30] DFND 1,691,638 1,691,638
State Street Corp [2025-06-30] DFND 1,193,442 1,265,847
Krensavage Asset Management LLC [2025-06-30] SOLE 1,024,883 1,024,883
Morgan Stanley [2025-06-30] DFND 746,770 900,477
Caption Management LLC [2025-06-30] SOLE 884,486 884,486
Citigroup Inc [2025-06-30] DFND 880,603 880,603
Connor Clark & Lunn Investment Management Ltd [2025-06-30] SOLE 868,419 868,419
Two Sigma Advisers LP [2025-06-30] SOLE 770,600 809,200
Federated Hermes Inc [2025-06-30] DFND 728,494 728,494
Prudential Financial Inc [2025-06-30] DFND 600,789 606,003
Two Sigma Investments LP [2025-06-30] SOLE 526,866 526,866
Marshall Wace LLP [2025-06-30] OTR 0 471,720
Northern Trust Corp [2025-06-30] DFND 449,862 450,211
Charles Schwab Investment Management Inc [2025-06-30] SOLE 450,207 450,207
Susquehanna International Group LLP [2025-06-30] OTR 177,251 411,151
Goldman Sachs Group Inc [2025-06-30] DFND 405,286 406,731
GSA Capital Partners LLP [2025-06-30] SOLE 382,071 382,071
Profit Investment Management LLC [2025-06-30] SOLE 329,822 329,822
Schroder Investment Management Group [2025-06-30] SOLE 307,176 307,176
Monaco Asset Management SAM [2025-06-30] SOLE 305,000 305,000
Wellington Management Group LLP [2025-06-30] DFND 0 292,495
Stonepine Capital Management LLC [2025-06-30] SOLE 250,000 250,000
Kennedy Capital Management LLC [2025-06-30] SOLE 237,468 237,468
Barclays PLC [2025-06-30] SOLE 224,404 224,404
Prev | Page 4 | Next
Terms | Privacy | Guide
tony@aum13f.com